DEUTSCHE BANK AG\ - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 74 filers reported holding TRINITY BIOTECH PLC in Q4 2013. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2019$9,000
-91.6%
7,478
-88.5%
0.00%
Q2 2019$107,000
-9.3%
65,200
+57.1%
0.00%
Q1 2019$118,000
+12.4%
41,500
-10.0%
0.00%
Q4 2018$105,000
-85.4%
46,100
-74.4%
0.00%
Q3 2018$719,000
-14.6%
179,959
+6.7%
0.00%
Q2 2018$842,000
+169.9%
168,585
+177.4%
0.00%
Q1 2018$312,000
+54.5%
60,772
+53.1%
0.00%
Q4 2017$202,00039,693
+3969200.0%
0.00%
Q3 2017$010.0%0.00%
Q2 2017$010.0%0.00%
Q1 2017$0
-100.0%
1
-99.9%
0.00%
Q4 2016$4,000
-99.1%
713
-97.9%
0.00%
Q3 2016$446,000
+4360.0%
33,752
+3604.9%
0.00%
Q2 2016$10,000
-96.0%
911
-95.8%
0.00%
Q1 2016$251,000
+25000.0%
21,559
+22593.7%
0.00%
Q4 2015$1,000
-99.9%
95
-99.9%
0.00%
-100.0%
Q3 2015$1,100,000
+23.6%
96,274
+94.9%
0.00%0.0%
Q2 2015$890,000
+86.6%
49,389
+98.8%
0.00%
Q1 2015$477,000
+7.0%
24,841
-2.7%
0.00%
Q4 2014$446,000
+48.2%
25,540
+55.0%
0.00%
Q3 2014$301,000
-25.7%
16,480
-6.4%
0.00%
Q2 2014$405,000
+46.2%
17,614
+53.7%
0.00%
Q1 2014$277,000
+454.0%
11,461
+473.0%
0.00%
Q4 2013$50,000
-43.2%
2,000
-51.1%
0.00%
Q3 2013$88,0004,0930.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q4 2013
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders